Search
for
Sort by
Research 541–570 of 1000+
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Cutaneous manifestations of systemic infection in children
- Quoi de neuf en recherche dermatologique ?
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Androgen binding profiles of two distinct nuclear androgen receptors in Atlantic croaker (Micropogonias undulatus)
- Localization of varicella-zoster virus nucleic acids and proteins in human skin
- Expression of COX-2 and Bcl-2 in 50 patients of Lichen Planus
- Primary Cicatricial Alopecia Successfully Treated with A Combination of Oral Zinc with Nd: YAG Laser. A Case Series of Five Patients
- Variant <i>PADI3</i> in Central Centrifugal Cicatricial Alopecia
- ROR2 regulates self-renewal and maintenance of hair follicle stem cells
- Neuroimmunology of Stress: Skin Takes Center Stage
- Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
- Severe cutaneous adverse reactions to drugs
- Transforming growth factor-β in stem cells and tissue homeostasis
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Treatment of Alopecia Areata With Tofacitinib
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study
- Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Graft-versus-host disease
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options